The Latin America, Middle East and Africa Tumor Ablation Market is expected to witness market growth of 13.2% CAGR during the forecast period (2019-2025).
The ablation market for tumors in the Middle East & Africa is fueled by factors such as the growing aging population and the increased number of people suffering from cancer. An increase in the demand for minimally invasive cancer treatment procedures and high awareness of the benefits that ablation procedures offer over conventional surgical procedures are also among the key factors that add up to market growth.
Microwave tumor ablation technology has been the fastest-growing category of ablation technology currently used to manage various cancers (like lung, liver, and kidney). Growth in the microwave ablation segment can be attributed to increased private funding for new microwave ablation product development, drastic efficiency over other ablation technologies, and increased adoption by Healthcare professionals of the microwave tumor ablation procedure to treat different cancers.
The percutaneous ablation techniques are well known in cancer treatment for both cure and local regulation of many forms of tumors. Tumor tissue cryoablation leads to cell destruction by freezing. Cryoablation leads to tumor cell death by osmosis and necrosis, in comparison to heat-based ablative modalities. It is observed that the intracellular contents of cancer cells remain intact with necrosis allowing an immune-specific reaction to being induced by the immune system.
Based on Treatment, the market is segmented into Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. Based on Technology, the market is segmented into Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation and Other Technology. Based on Application, the market is segmented into Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Cancer. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Johnson and Johnson (Ethicon, Inc.), Boston Scientific Corporation, Misonix, Inc., EDAP TMS S.A., Theraclion SA, AngioDynamics, Inc., Mermaid Medical A/S, HealthTronics, Inc. (Altaris Capital Partners, LLC), and SonaCare Medical, LLC.
Scope of the Study
Market Segmentation:
By Treatment
By Technology
By Application
By Country
Companies Profiled
Unique Offerings from the Publisher
The ablation market for tumors in the Middle East & Africa is fueled by factors such as the growing aging population and the increased number of people suffering from cancer. An increase in the demand for minimally invasive cancer treatment procedures and high awareness of the benefits that ablation procedures offer over conventional surgical procedures are also among the key factors that add up to market growth.
Microwave tumor ablation technology has been the fastest-growing category of ablation technology currently used to manage various cancers (like lung, liver, and kidney). Growth in the microwave ablation segment can be attributed to increased private funding for new microwave ablation product development, drastic efficiency over other ablation technologies, and increased adoption by Healthcare professionals of the microwave tumor ablation procedure to treat different cancers.
The percutaneous ablation techniques are well known in cancer treatment for both cure and local regulation of many forms of tumors. Tumor tissue cryoablation leads to cell destruction by freezing. Cryoablation leads to tumor cell death by osmosis and necrosis, in comparison to heat-based ablative modalities. It is observed that the intracellular contents of cancer cells remain intact with necrosis allowing an immune-specific reaction to being induced by the immune system.
Based on Treatment, the market is segmented into Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. Based on Technology, the market is segmented into Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation and Other Technology. Based on Application, the market is segmented into Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Cancer. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Johnson and Johnson (Ethicon, Inc.), Boston Scientific Corporation, Misonix, Inc., EDAP TMS S.A., Theraclion SA, AngioDynamics, Inc., Mermaid Medical A/S, HealthTronics, Inc. (Altaris Capital Partners, LLC), and SonaCare Medical, LLC.
Scope of the Study
Market Segmentation:
By Treatment
- Surgical Ablation
- Laparoscopic Ablation and
- Percutaneous Ablation
By Technology
- Radiofrequency Ablation
- Microwave Ablation
- Cryoablation
- Irreversible Electroporation and
- Other Technology
By Application
- Liver Cancer
- Breast Cancer
- Lung Cancer
- Kidney Cancer
- Prostate Cancer and
- Other Cancer
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Medtronic PLC
- Johnson and Johnson (Ethicon, Inc.)
- Boston Scientific Corporation
- Misonix, Inc.
- EDAP TMS S.A.
- Theraclion SA
- AngioDynamics, Inc.
- Mermaid Medical A/S
- HealthTronics, Inc. (Altaris Capital Partners, LLC)
- SonaCare Medical, LLC
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. LAMEA Tumor Ablation Market by Treatment
Chapter 5. LAMEA Tumor Ablation Market by Technology
Chapter 6. LAMEA Tumor Ablation Market by Application
Chapter 7. LAMEA Tumor Ablation Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Medtronic PLC
- Johnson and Johnson (Ethicon, Inc.)
- Boston Scientific Corporation
- Misonix, Inc.
- EDAP TMS S.A.
- Theraclion SA
- AngioDynamics, Inc.
- Mermaid Medical A/S
- HealthTronics, Inc. (Altaris Capital Partners, LLC)
- SonaCare Medical, LLC
Methodology
LOADING...